Neogen CorporationNEOGNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank7
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P7
Near historical low
vs 5Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-6.18%
2024-13.68%
202352.73%
20224.94%
202110.15%
202015.19%
201917.96%
20184.53%
20175.01%
20163.27%